examples of glp 1 analogues GLP-1 and Anesthesia: Considerations and Cautions for CRNAs From metabolism to mind: The

Replacement of osteogenic cells with BMAT decreases bone quality and contributes to an overall poor metabolic environment

GLP-1/glucagon co-agonists The development of these unimolecular formulations targeting both GLP-1 and glucagon receptors enhances the anorectic effect of GLP-1, provides a lipolytic and lipogenesis-inhibiting effect (Table 2)particularly at the hepatic leveland promotes thermogenic activity, thereby facilitating weight reduction and the treatment of MASLD.1,5,35 Survodutide generates dose-dependent weight reduction of up to 14.9% in 46 weeks.49 It is shown to be effective in reducing liver fat and improving MASH in up to 62% of participants treated with weekly injection of 4.8 mg

doi: 10.1111/joim.12012

For the right weight loss candidates, Dr